ArticleCPT: pharmacometrics & systems pharmacology2022

Population pharmacokinetic/pharmacodynamic joint modeling of ixazomib efficacy and safety using data from the pivotal phase III TOURMALINE-MM1 study in multiple myeloma patients.

Jaydeep K Srimani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.